Stock Analysis on Net
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 
Quarterly Data

Abbott Laboratories, common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Short-term borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.27 0.27 0.27 0.29 0.30 0.30 0.31
Trade accounts payable 5.17 5.15 5.43 5.65 5.77 5.87 5.49 5.74 5.65 6.19 5.68 6.06 6.43 5.86 5.44 5.48 5.59 5.44 4.62 4.85 4.76
Salaries, wages and commissions 1.43 2.09 2.18 1.90 1.51 2.18 2.05 1.86 1.49 2.09 1.96 1.77 1.55 2.16 1.99 1.70 1.53 1.95 2.08 1.63 1.42
Other accrued liabilities 6.88 6.32 7.30 6.94 7.20 7.41 7.42 7.27 7.80 7.85 7.52 7.28 7.54 6.89 7.13 7.31 7.21 7.12 6.75 6.12 6.60
Dividends payable 1.27 1.26 1.29 1.31 1.32 1.30 1.23 1.21 1.20 1.19 1.13 1.11 1.11 1.11 1.08 1.09 1.10 1.10 0.93 0.93 0.95
Income taxes payable 0.60 0.73 0.96 0.82 0.78 0.67 0.44 0.37 0.45 0.46 0.54 0.48 0.46 0.41 0.50 0.33 0.38 0.50 0.17 0.24 0.25
Current portion of long-term debt 0.62 1.84 2.90 2.21 2.77 1.48 1.46 3.11 3.10 3.02 1.53 0.01 0.01 1.00 1.02 1.03 1.04 0.01 0.01 1.88 1.89
Current liabilities 15.97% 17.39% 20.04% 18.84% 19.35% 18.90% 18.09% 19.56% 19.69% 20.81% 18.36% 16.70% 17.09% 17.43% 17.44% 17.22% 17.12% 16.41% 14.86% 15.93% 16.19%
Long-term debt, excluding current portion 15.64 15.51 17.25 17.99 17.35 18.57 20.08 19.85 19.81 19.51 21.01 22.58 23.09 23.00 23.64 23.95 24.03 25.54 26.58 26.44 25.16
Post-employment obligations, deferred income taxes and other long-term liabilities 8.16 8.27 8.88 8.98 9.42 9.49 9.54 9.59 10.05 10.11 11.34 11.24 11.68 11.66 11.98 12.39 12.43 12.56 12.81 12.85 13.09
Long-term liabilities 23.79% 23.77% 26.13% 26.98% 26.77% 28.06% 29.62% 29.45% 29.86% 29.61% 32.35% 33.82% 34.77% 34.67% 35.63% 36.34% 36.46% 38.10% 39.38% 39.29% 38.25%
Total liabilities 39.76% 41.16% 46.17% 45.82% 46.12% 46.97% 47.71% 49.01% 49.55% 50.42% 50.71% 50.52% 51.86% 52.09% 53.06% 53.56% 53.58% 54.51% 54.24% 55.22% 54.43%
Preferred shares, one dollar par value, none issued 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common shares, without par value, issued at stated capital amount 30.85 30.90 33.65 34.04 34.12 33.97 34.30 33.55 33.18 33.19 33.74 32.92 32.84 32.54 32.91 32.96 33.01 33.28 34.81 34.74 35.54
Common shares held in treasury, at cost -20.40 -20.69 -22.16 -21.58 -21.75 -21.83 -21.76 -21.43 -20.74 -20.46 -19.99 -18.49 -18.55 -15.72 -14.90 -14.11 -13.53 -13.84 -14.30 -14.40 -14.84
Earnings employed in the business 58.58 58.05 52.53 52.53 52.45 51.29 51.21 49.56 48.61 47.36 48.23 46.48 44.99 41.93 41.16 39.65 39.39 38.08 38.04 37.32 38.62
Accumulated other comprehensive loss -9.11 -9.71 -10.50 -11.14 -11.27 -10.71 -11.76 -11.00 -10.89 -10.82 -12.97 -11.73 -11.45 -11.14 -12.52 -12.37 -12.76 -12.33 -13.10 -13.20 -14.06
Total Abbott shareholders’ investment 59.93% 58.55% 53.52% 53.85% 53.56% 52.73% 51.99% 50.68% 50.15% 49.28% 49.00% 49.18% 47.83% 47.61% 46.65% 46.13% 46.11% 45.19% 45.46% 44.46% 45.25%
Noncontrolling interests in subsidiaries 0.31 0.29 0.31 0.33 0.32 0.31 0.30 0.31 0.30 0.29 0.29 0.30 0.31 0.30 0.29 0.31 0.31 0.30 0.30 0.32 0.31
Total shareholders’ investment 60.24% 58.84% 53.83% 54.18% 53.88% 53.03% 52.29% 50.99% 50.45% 49.58% 49.29% 49.48% 48.14% 47.91% 46.94% 46.44% 46.42% 45.49% 45.76% 44.78% 45.57%
Total liabilities and shareholders’ investment 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).

Short-term Borrowings
The proportion of short-term borrowings relative to total liabilities and shareholders’ investment showed a slight decline from 0.31% in March 2020 to 0.27% by December 2021. Data for subsequent periods is unavailable, indicating either a reduction to an immaterial level or omission in reporting.
Trade Accounts Payable
This liability component increased steadily from 4.76% in March 2020 to a peak of 6.43% in March 2022, followed by fluctuations remaining mostly between 5.15% and 6.19% from mid-2022 into early 2025, reflecting a moderate variability but a generally higher weighting compared to the start of the period.
Salaries, Wages and Commissions
The share of this expense item increased from 1.42% in March 2020 to peaks around 2.18% in late 2021 and again in late 2024, with intermittent declines. The pattern suggests periodic increases that may relate to seasonal factors or operational fluctuations.
Other Accrued Liabilities
Values exhibited modest volatility, initially declining from 6.60% in March 2020 to around 6.12%-6.60% during 2020, then rising to a high near 7.85% in late 2022. Thereafter, a slight downward trend ensued, ending near 6.88% in early 2025. This indicates fluctuations in accrued obligations over time.
Dividends Payable
Dividends payable increased steadily from 0.95% in early 2020 to around 1.32% by mid-2024, followed by a slight decrease to approximately 1.27% by March 2025, signaling an upward trend in shareholder distributions within the period.
Income Taxes Payable
This liability demonstrated variability, starting at 0.25% in March 2020 and rising generally through the timeline to a peak near 0.96% in late 2024, before dropping to 0.60% in early 2025, indicating fluctuations in tax liabilities that may correlate with earnings and tax planning.
Current Portion of Long-term Debt
The proportion experienced significant fluctuations, starting at 1.89% in early 2020, dropping close to zero mid-2020 and late-2021, then rising sharply to over 3% by late 2022 and early 2023. Subsequent quarters saw oscillations with values between 0.62% and 2.90%, reflecting active debt refinancing or repayments.
Current Liabilities
Overall, current liabilities increased from 16.19% in March 2020 to a peak of 20.81% by late 2022, before declining toward 15.97% by March 2025. The pattern shows an accumulation of short-term obligations around 2022 followed by a reduction.
Long-term Debt Excluding Current Portion
A clear downward trend was observed, from 25.16% in early 2020 to approximately 15.64% by early 2025, implying a reduction in long-term indebtedness over the period under review.
Post-employment Obligations, Deferred Income Taxes, and Other Long-term Liabilities
This category steadily declined from 13.09% in March 2020 to 8.16% by March 2025, suggesting improvements in pension or deferred tax liabilities or changes in accounting estimates or obligations.
Long-term Liabilities
Long-term liabilities decreased from 38.25% in early 2020 to 23.79% by early 2025, consistent with the reductions observed in debt and other long-term obligations, reinforcing a deleveraging trend in longer-term liabilities.
Total Liabilities
Total liabilities fell substantially from 54.43% of total capital structure in March 2020 to 39.76% by March 2025, illustrating a significant shift toward lower leverage.
Common Shares, Without Par Value, Issued at Stated Capital Amount
The equity share represented by common shares was relatively steady, fluctuating around 33% to 35% through most of the measurement period before declining to approximately 30.85% by March 2025.
Common Shares Held in Treasury, at Cost
Treasury shares showed a growing negative proportion from -14.84% in March 2020 to around -22.16% by late 2024, with a slight recovery near -20.40% by early 2025, indicating increasing buybacks or retained shares over time.
Earnings Employed in the Business
This component steadily increased from 38.62% in early 2020 to 58.58% by March 2025, suggesting accumulation of retained earnings and stronger reinvestment or profitability contributing to equity growth.
Accumulated Other Comprehensive Loss
There was a steady reduction in the comprehensive loss from -14.06% in early 2020 to -9.11% by early 2025, indicating an improvement in components such as foreign currency translation or other comprehensive income items.
Total Abbott Shareholders’ Investment
Shareholders’ equity generally increased over the observed period, rising from 45.25% to nearly 59.93% by early 2025, reflecting stronger equity base in the capital structure overall.
Noncontrolling Interests in Subsidiaries
Noncontrolling interests remained relatively stable around 0.29% to 0.33%, showing no significant change in minority interests.
Total Shareholders’ Investment
The total shareholders’ investment increased steadily from 45.57% in March 2020 to 60.24% by March 2025, indicating a shift toward greater equity financing and a reduction in leverage.
Total Liabilities and Shareholders’ Investment
Remained constant at 100%, serving as the base for all ratios reported.